{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:12:25Z","timestamp":1775074345791,"version":"3.50.1"},"reference-count":46,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1620\/tjem.239.297","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T18:01:55Z","timestamp":1470160915000},"page":"297-305","source":"Crossref","is-referenced-by-count":33,"title":["High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis"],"prefix":"10.1620","volume":"239","author":[{"given":"Fumiko","family":"Tomiyama","sequence":"first","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Kamogawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Shirota","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Sugimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O. 3rd., Birnbaum, N.S., Burmester, G.R., Bykerk, V.P., Cohen, M.D., Combe, B., Costenbader, K.H., Dougados, M., Emery, P., Ferraccioli, G., et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. <i>Arthritis Rheum.<\/i>, 62, 2569-2581.","DOI":"10.1002\/art.27584"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ando, K., Motojima, S., Doi, T., Nagaoka, T., Kaneko, N., Aoshima, M. &amp; Takahashi, K. (2013) Effect of glucocorticoid monotherapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung disease. <i>Respir. Investig.<\/i>, 51, 69-75.","DOI":"10.1016\/j.resinv.2012.12.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., Sato, A. &amp; Kudoh, S. (2005) Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. <i>Am. J. Respir. Crit. Care Med.<\/i>, 171, 1040-1047.","DOI":"10.1164\/rccm.200404-571OC"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bohan, A. &amp; Peter, J.B. (1975) Polymyositis and dermatomyositis (first of two parts). <i>N. Engl. J. Med.<\/i>, 292, 344-347.","DOI":"10.1056\/NEJM197502132920706"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Broen, J.C., Radstake, T.R. &amp; Rossato, M. (2014) The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. <i>Nat. Rev. Rheumatol.<\/i>, 10, 671-681.","DOI":"10.1038\/nrrheum.2014.128"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Bussone, G. &amp; Mouthon, L. (2011) Interstitial lung disease in systemic sclerosis. <i>Autoimmun. Rev.<\/i>, 10, 248-255.","DOI":"10.1016\/j.autrev.2010.09.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Cappelli, S., Bellando-Randone, S., Camiciottoli, G., De Paulis, A., Guiducci, S. &amp; Matucci-Cerinic, M. (2015) Interstitial lung disease in systemic sclerosis: where do we stand? <i>Eur. Respir. Rev.<\/i>, 24, 411-419.","DOI":"10.1183\/16000617.00002915"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Clements, P.J., Hurwitz, E.L., Wong, W.K., Seibold, J.R., Mayes, M., White, B., Wigley, F., Weisman, M., Barr, W., Moreland, L., Medsger, T.A. Jr., Steen, V.D., Martin, R.W., Collier, D., Weinstein, A., et al. (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. <i>Arthritis Rheum.<\/i>, 43, 2445-2454.","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Collard, H.R., Moore, B.B., Flaherty, K.R., Brown, K.K., Kaner, R.J., King, T.E. Jr., Lasky, J.A., Loyd, J.E., Noth, I., Olman, M.A., Raghu, G., Roman, J., Ryu, J.H., Zisman, D.A., Hunninghake, G.W., et al. (2007) Acute exacerbations of idiopathic pulmonary fibrosis. <i>Am. J. Respir. Crit. Care Med.<\/i>, 176, 636-643.","DOI":"10.1164\/rccm.200703-463PP"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Czirjak, L., Kumanovics, G., Varju, C., Nagy, Z., Pakozdi, A., Szekanecz, Z. &amp; Szucs, G. (2008) Survival and causes of death in 366 Hungarian patients with systemic sclerosis. <i>Ann. Rheum. Dis.<\/i>, 67, 59-63.","DOI":"10.1136\/ard.2006.066340"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Fan, M.H., Feghali-Bostwick, C.A. &amp; Silver, R.M. (2014) Update on scleroderma-associated interstitial lung disease. <i>Curr. Opin. Rheumatol.<\/i>, 26, 630-636.","DOI":"10.1097\/BOR.0000000000000111"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Ferri, C., Sebastiani, M., Lo Monaco, A., Iudici, M., Giuggioli, D., Furini, F., Manfredi, A., Cuomo, G., Spinella, A., Colaci, M., Govoni, M. &amp; Valentini, G. (2014) Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients\u2019 population and review of the literature. <i>Autoimmun. Rev.<\/i>, 13, 1026-1034.","DOI":"10.1016\/j.autrev.2014.08.029"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Fujibayashi, T., Sugai, S., Miyasaka, N., Hayashi, Y. &amp; Tsubota, K. (2004) Revised Japanese criteria for Sj\u00f6gren\u2019s syndrome (1999): availability and validity. <i>Mod. Rheumatol.<\/i>, 14, 425-434.","DOI":"10.3109\/s10165-004-0338-x"},{"key":"14","unstructured":"Furst, D.E., Clements, P.J., Steen, V.D., Medsger, T.A. Jr., Masi, A.T., D\u2019Angelo, W.A., Lachenbruch, P.A., Grau, R.G. &amp; Seibold, J.R. (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. <i>J. Rheumatol.<\/i>, 25, 84-88."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Gabrielli, A., Avvedimento, E.V. &amp; Krieg, T. (2009) Scleroderma. <i>N. Engl. J. Med.<\/i>, 360, 1989-2003.","DOI":"10.1056\/NEJMra0806188"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hashimoto, A., Endo, H., Kondo, H. &amp; Hirohata, S. (2012) Clinical features of 405 Japanese patients with systemic sclerosis. <i>Mod. Rheumatol.<\/i>, 22, 272-279.","DOI":"10.3109\/s10165-011-0515-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Hashimoto, A., Tejima, S., Tono, T., Suzuki, M., Tanaka, S., Matsui, T., Tohma, S., Endo, H. &amp; Hirohata, S. (2011) Predictors of survival and causes of death in Japanese patients with systemic sclerosis. <i>J. Rheumatol.<\/i>, 38, 1931-1939.","DOI":"10.3899\/jrheum.100298"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., Melchers, I., Meurer, M., Moinzadeh, P., Muller-Ladner, U., Pfeiffer, C., Riemekasten, G., Schulze-Lohoff, E., Sunderkoetter, C., Weber, M., Worm, M., Klaus, P., et al. (2008) The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. <i>Rheumatology <\/i>(<i>Oxford<\/i>), 47, 1185-1192.","DOI":"10.1093\/rheumatology\/ken179"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Ioannidis, J.P., Vlachoyiannopoulos, P.G., Haidich, A.B., Medsger, T.A. Jr., Lucas, M., Michet, C.J., Kuwana, M., Yasuoka, H., van den Hoogen, F., Te Boome, L., van Laar, J.M., Verbeet, N.L., Matucci-Cerinic, M., Georgountzos, A. &amp; Moutsopoulos, H.M. (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. <i>Am. J. Med.<\/i>, 118, 2-10.","DOI":"10.1016\/j.amjmed.2004.04.031"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Ishizuka, M., Watanabe, R., Ishii, T., Machiyama, T., Akita, K., Fujita, Y., Shirota, Y., Fujii, H. &amp; Harigae, H. (2016) Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors. <i>Mod. Rheumatol.<\/i>, 26, 115-120.","DOI":"10.3109\/14397595.2015.1054081"},{"key":"21","unstructured":"Jacobsen, S., Ullman, S., Shen, G.Q., Wiik, A. &amp; Halberg, P. (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. <i>J. Rheumatol.<\/i>, 28, 2454-2459."},{"key":"22","doi-asserted-by":"crossref","unstructured":"Joseph, C.G., Darrah, E., Shah, A.A., Skora, A.D., Casciola-Rosen, L.A., Wigley, F.M., Boin, F., Fava, A., Thoburn, C., Kinde, I., Jiao, Y., Papadopoulous, N., Kinzler, K.W., Volgelstein, B. &amp; Rosen, A. (2014) Association of the autoimmune disease scleroderma with an immunologic response to cancer. <i>Science<\/i>, 343, 152-157.","DOI":"10.1126\/science.1246886"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Kaji, K., Fertig, N., Medsger, T.A. Jr., Satoh, T., Hoshino, K., Hamaguchi, Y., Hasegawa, M., Lucas, M., Schnure, A., Ogawa, F., Sato, S., Takehara, K., Fujimoto, M. &amp; Kuwana, M. (2014) Autoantibodies to RubBL1 and Rub BL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. <i>Arthritis Care Res.<\/i>, 66, 575-584.","DOI":"10.1002\/acr.22163"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Kanda, Y. (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Transplant.<\/i>, 48, 452-458.","DOI":"10.1038\/bmt.2012.244"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Kondoh, Y., Taniguchi, H., Kawabata, Y., Yokoi, T., Suzuki, K. &amp; Takagi, K. (1993) Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathological findings in three cases. <i>Chest<\/i>, 103, 1808-1812.","DOI":"10.1378\/chest.103.6.1808"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Kowal-Bielecka, O., Landewe, R., Avouac, J., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., Foldvari, I., Furst, D.E., Muller-Ladner, U., Seibold, J., Silver, R.M., et al. (2009) EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). <i>Ann. Rheum. Dis.<\/i>, 68, 620-628.","DOI":"10.1136\/ard.2008.096677"},{"key":"27","unstructured":"LeRoy, E.C., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T.A. Jr., Rowell, N. &amp; Wollheim, F. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. <i>J. Rheumatol.<\/i>, 15, 202-205."},{"key":"28","doi-asserted-by":"crossref","unstructured":"Mathai, S.C. &amp; Danoff, S.K. (2016) Management of interstitial lung disease associated with connective tissue disease. <i>BMJ<\/i>, 352, h6819.","DOI":"10.1136\/bmj.h6819"},{"key":"29","unstructured":"Meyer, O.C., Fertig, N., Lucas, M., Somogyi, N. &amp; Medsger, T.A. Jr. (2007) Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. <i>J. Rheumatol.<\/i>, 34, 104-109."},{"key":"30","doi-asserted-by":"crossref","unstructured":"Moinzadeh, P., Aberer, E., Ahmadi-Simab, K., Blank, N., Distler, J.H., Fierlbeck, G., Genth, E., Guenther, C., Hein, R., Henes, J., Herich, L., Herrgott, I., Koetter, I., Kreuter, A., Krieg, T., et al. (2015) Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. <i>Ann. Rheum. Dis.<\/i>, 74, 730-737.","DOI":"10.1136\/annrheumdis-2013-204487"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Moinzadeh, P., Fonseca, C., Hellmich, M., Shah, A.A., Chighizola, C., Denton, C.P. &amp; Ong, V.H. (2014) Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma. <i>Arthritis Res. Ther.<\/i>, 16, R53.","DOI":"10.1186\/ar4486"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Nihtyanova, S.I. &amp; Denton, C.P. (2010) Autoantibodies as predictive tools in systemic sclerosis. <i>Nat. Rev. Rheumatol.<\/i>, 6, 112-116.","DOI":"10.1038\/nrrheum.2009.238"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Nihtyanova, S.I., Schreiber, B.E., Ong, V.H., Rosenberg, D., Moinzadeh, P., Coghlan, J.G., Wells, A.U. &amp; Denton, C.P. (2014) Prediction of pulmonary complications and long-term survival in systemic sclerosis. <i>Arthritis Rheum.<\/i>, 66, 1625-1635.","DOI":"10.1002\/art.38390"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Pakozdi, A., Nihtyanova, S., Moinzadeh, P., Ong, V.H., Black, C.M. &amp; Denton, C.P. (2011) Clinical and serological hallmarks of systemic sclerosis overlap syndromes. <i>J. Rheumatol.<\/i>, 38, 2406-2409.","DOI":"10.3899\/jrheum.101248"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Park, I.N., Kim, D.S., Shim, T.S., Lim, C.M., Lee, S.D., Koh, Y., Kim, W.S., Kim, W.D., Jang, S.J. &amp; Colby, T.V. (2007) Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. <i>Chest<\/i>, 132, 214-220.","DOI":"10.1378\/chest.07-0323"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Ryerson, C.J., Cottin, V., Brown, K.K. &amp; Collard, H.R. (2015) Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm. <i>Eur. Repir. J.<\/i>, 46, 512-520.","DOI":"10.1183\/13993003.00419-2015"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Shirai, Y., Okazaki, Y., Inoue, Y., Tamura, Y., Yasuoka, H., Takeuchi, T. &amp; Kuwana, M. (2015) Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis. <i>Arthritis Rheumatol.<\/i>, 67, 498-507.","DOI":"10.1002\/art.38953"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Steen, V.D. &amp; Medsger, T.A. (2007) Changes in causes of death in systemic sclerosis, 1972-2002. <i>Ann. Rheum. Dis.<\/i>, 66, 940-944.","DOI":"10.1136\/ard.2006.066068"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Suda, T., Kaida, Y., Nakamura, Y., Enomoto, N., Fujisawa, T., Imokawa, S., Hashizume, H., Naito, T., Hashimoto, D., Takehara, Y., Inui, N., Nakamura, H., Colby, T.V. &amp; Chida, K. (2009) Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. <i>Respir. Med.<\/i>, 103, 846-853.","DOI":"10.1016\/j.rmed.2008.12.019"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Tachikawa, R., Tomii, K., Ueda, H., Nagata, K., Nanjo, S., Sakurai, A., Otsuka, K., Kaji, R., Hayashi, M., Katakami, N. &amp; Imai, Y. (2012) Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular disease-related versus idiopathic. <i>Respiration<\/i>, 83, 20-27.","DOI":"10.1159\/000329893"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Tashkin, D.P., Elashoff, R., Clements, P.J., Goldin, J., Roth, M.D., Furst, D.E., Arriola, E., Silver, R., Strange, C., Bolster, M., Seibold, J.R., Riley, D.J., Hsu, V.M., Varga, J., Schraufnagel, D.E., et al. (2006) Cyclophosphamide versus placebo in scleroderma lung disease. <i>N. Engl. J. Med.<\/i>, 354, 2655-2666.","DOI":"10.1056\/NEJMoa055120"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Tashkin, D.P., Elashoff, R., Clements, P.J., Roth, M.D., Furst, D.E., Silver, R.M., Goldin, J., Arriola, E., Strange, C., Bolster, M., Seibold, J.R., Riley, D.J., Hsu, V.M., Varga, J., Schraufnagel, D.E., et al. (2007) Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. <i>Am. J. Respir. Crit. Care Med.<\/i>, 176, 1026-1034.","DOI":"10.1164\/rccm.200702-326OC"},{"key":"43","doi-asserted-by":"crossref","unstructured":"van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S.R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R.P., Medsger, T.A. Jr., Carreira, P.E., Riemekasten, G., Clements, P.J., Denton, C.P., Distler, O., Allnore, Y., et al. (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. <i>Arthritis Rheum.<\/i>, 65, 2737-2747.","DOI":"10.1002\/art.38098"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Wells, A.U. &amp; Denton, C.P. (2014) Interstitial lung disease in connective tissue disease-mechanisms and management. <i>Nat. Rev. Rheumatol.<\/i>, 10, 728-739.","DOI":"10.1038\/nrrheum.2014.149"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Yasuoka, H. (2016) Recent treatments of interstitial lung disease with systemic sclerosis. <i>Clin. Med. Insights Circ. Respir. Pulm. Med.<\/i>, 9, 97-110.","DOI":"10.4137\/CCRPM.S23315"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Yoshida, M., Watanabe, R., Ishii, T., Machiyama, T., Akita, K., Fujita, Y., Shirota, Y., Sugimura, K., Fujii, H., Shimokawa, H. &amp; Harigae, H. (2016) Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience. <i>Int. J. Rheum. Dis.<\/i>, 19, 87-94.","DOI":"10.1111\/1756-185X.12777"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/239\/4\/239_297\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:46:56Z","timestamp":1498319216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/239\/4\/239_297\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.239.297","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}